Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Habedank

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal of the American College of Cardiology|September 19, 2009
Renal protective effects and prevention of contrast-induced nephropathy by atrial natriuretic peptide can it work?Michael Haase, Anja Haase-Fielitz, Dirk Habedank, et al.
Journal of Cardiology Cases|April 4, 2023
Subtotal occlusion of the right coronary artery by Cardioband and its successful intervention via retrograde approach. Interventional flashlightDirk Habedank, Sabine Bierschenk, Saskia Zimpel, et al.
BMC Cardiovascular Disorders|January 1, 2022
Near fatal stent thrombosis in an aneurysmatic RCX as first manifestation of heparin induced thrombocytopenia (HIT) without thrombocytopeniaMarc Zoller, Iskandar Atmowihardjo, Jeanette Huch, et al.
Lancet (London, England)|May 12, 2004
Procalcitonin-guided antibiotic treatment in heart failureAnja Sandek, Jochen Springer, Dirk Habedank, et al.
BMC Pulmonary Medicine|March 29, 2023
Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation - a case reportRalf Ewert, Mohamed A Elhadad, Dirk Habedank, et al.
Respiratory Medicine|March 1, 2021
Intravenous prostacyclin-analogue therapy in pulmonary arterial hypertension - A review of the past, present and futureBeate Stubbe, Christian F Opitz, Michael Halank, et al.
Expert Review of Respiratory Medicine|November 30, 2021
Strategies for optimizing intravenous prostacyclin-analog therapy in patients with pulmonary arterial hypertensionRalf Ewert, Dirk Habedank, Michael Halank, et al.
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|January 9, 2019
Predictive Capability of Cardiopulmonary and Exercise Parameters From Day 1 to 6 Months After Acute Pulmonary EmbolismDirk Habedank, Christian Opitz, Tim Karhausen, et al.
Clinical Case Reports|December 28, 2020
Ventricular fibrillation and Takotsubo cardiomyopathy triggered by media panic on COVID-19: A case reportDirk Habedank, Roland Thieme, Angelika Bublak, et al.
ESC Heart Failure|May 3, 2021
Inhalation of publicly available indoor insecticide spray caused myocardial infarction type II: a case reportDirk Habedank, Beate Stubbe, Ralf Ewert, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of the American College of Cardiology|September 19, 2009
Renal protective effects and prevention of contrast-induced nephropathy by atrial natriuretic peptide can it work?Michael Haase, Anja Haase-Fielitz, Dirk Habedank, et al.
Journal of Cardiology Cases|April 4, 2023
Subtotal occlusion of the right coronary artery by Cardioband and its successful intervention via retrograde approach. Interventional flashlightDirk Habedank, Sabine Bierschenk, Saskia Zimpel, et al.
BMC Cardiovascular Disorders|January 1, 2022
Near fatal stent thrombosis in an aneurysmatic RCX as first manifestation of heparin induced thrombocytopenia (HIT) without thrombocytopeniaMarc Zoller, Iskandar Atmowihardjo, Jeanette Huch, et al.
Lancet (London, England)|May 12, 2004
Procalcitonin-guided antibiotic treatment in heart failureAnja Sandek, Jochen Springer, Dirk Habedank, et al.
BMC Pulmonary Medicine|March 29, 2023
Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation - a case reportRalf Ewert, Mohamed A Elhadad, Dirk Habedank, et al.
Respiratory Medicine|March 1, 2021
Intravenous prostacyclin-analogue therapy in pulmonary arterial hypertension - A review of the past, present and futureBeate Stubbe, Christian F Opitz, Michael Halank, et al.
Expert Review of Respiratory Medicine|November 30, 2021
Strategies for optimizing intravenous prostacyclin-analog therapy in patients with pulmonary arterial hypertensionRalf Ewert, Dirk Habedank, Michael Halank, et al.
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|January 9, 2019
Predictive Capability of Cardiopulmonary and Exercise Parameters From Day 1 to 6 Months After Acute Pulmonary EmbolismDirk Habedank, Christian Opitz, Tim Karhausen, et al.
Clinical Case Reports|December 28, 2020
Ventricular fibrillation and Takotsubo cardiomyopathy triggered by media panic on COVID-19: A case reportDirk Habedank, Roland Thieme, Angelika Bublak, et al.
ESC Heart Failure|May 3, 2021
Inhalation of publicly available indoor insecticide spray caused myocardial infarction type II: a case reportDirk Habedank, Beate Stubbe, Ralf Ewert, et al.
Pageof 5